MST1 and metabolic dysfunction-associated steatohepatitis: This study constructs a liver specific gene modification model and combines multi omics analysis to systematically analyze the molecular pathways through which MST1 regulates cholesterol metabolism, providing theoretical support for the development of precision therapies for NASH based on new targets [69, 70].